Literature DB >> 17763941

Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats.

Rebecca Banerjee1, Karuppagounder S Saravanan, Bobby Thomas, Kizhake M Sindhu, Kochupurackal P Mohanakumar.   

Abstract

In the present study we provide evidence for hydroxyl radical (*OH) scavenging action of nitric oxide (NO*), and subsequent dopaminergic neuroprotection in a hemiparkinsonian rat model. Reactive oxygen species are strongly implicated in the nigrostriatal dopaminergic neurotoxicity caused by the parkinsonian neurotoxin, 1-methyl-4-phenylpyridinium (MPP+). Since the role of this free radical as a neurotoxicant or neuroprotectant is debatable, we investigated the effects of some of the NO* donors such as S-nitroso-N-acetylpenicillamine (SNAP), 3-morpholinosydnonimine hydrochloride (SIN-1), sodium nitroprusside (SNP) and nitroglycerin (NG) on in vitro *OH generation in a Fenton-like reaction involving ferrous citrate, as well as in MPP+-induced *OH production in the mitochondria. We also tested whether co-administration of NO* donor and MPP+ could protect against MPP+-induced dopaminergic neurotoxicity in rats. While NG, SNAP and SIN-1 attenuated MPP+-induced *OH generation in the mitochondria, and in a Fenton-like reaction, SNP caused up to 18-fold increase in *OH production in the latter reaction. Striatal dopaminergic depletion following intranigral infusion of MPP+ in rats was significantly attenuated by NG, SNAP and SIN-1, but not by SNP. Solutions of NG, SNAP and SIN-1, exposed to air for 48 h to remove NO*, when administered similarly failed to attenuate MPP+-induced neurotoxicity in vivo. Conversely, long-time air-exposed SNP solution when administered in rats intranigrally, caused a dose-dependent depletion of the striatal dopamine. These results confirm the involvement of *OH in the nigrostriatal degeneration caused by MPP+, indicate the *OH scavenging ability of NO*, and demonstrate protection by NO* donors against MPP+-induced dopaminergic neurotoxicity in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763941     DOI: 10.1007/s11064-007-9473-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  63 in total

1.  Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity.

Authors:  Deepa S Maharaj; Himant Maharaj; Santy Daya; Beverley D Glass
Journal:  J Neurochem       Date:  2005-11-21       Impact factor: 5.372

Review 2.  Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note.

Authors:  B Halliwell; H Kaur; M Ingelman-Sundberg
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

3.  Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.

Authors:  K P Mohanakumar; D Muralikrishnan; B Thomas
Journal:  Brain Res       Date:  2000-05-12       Impact factor: 3.252

4.  Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.

Authors:  Kizhakke M Sindhu; Rebecca Banerjee; Karuppagounder S Senthilkumar; Karuppagounder S Saravanan; B China Raju; J Madhusudan Rao; Kochupurackal P Mohanakumar
Journal:  Pharmacol Biochem Behav       Date:  2006-07-03       Impact factor: 3.533

5.  Subcellular localization of neurotransmitters.

Authors:  V P Whittaker
Journal:  Adv Cytopharmacol       Date:  1971-05

6.  Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.

Authors:  S Rose; J G Hindmarsh; P Jenner
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

7.  Even after UVA-exposure will nitric oxide protect cells from reactive oxygen intermediate-mediated apoptosis and necrosis.

Authors:  C V Suschek; K Briviba; D Bruch-Gerharz; H Sies; K D Kröncke; V Kolb-Bachofen
Journal:  Cell Death Differ       Date:  2001-05       Impact factor: 15.828

Review 8.  Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions.

Authors:  Bianca Marchetti; Pier Andrea Serra; Cataldo Tirolo; Francesca L'episcopo; Salvo Caniglia; Florinda Gennuso; Nuccio Testa; Egidio Miele; Speranza Desole; Nicholas Barden; Maria Concetta Morale
Journal:  Brain Res Brain Res Rev       Date:  2005-04

Review 9.  Hydroxyl radicals and nitric oxide in neurotoxicity and neuroprotection.

Authors:  K P Mohanakumar; H W Steinbusch
Journal:  J Chem Neuroanat       Date:  1998-06       Impact factor: 3.052

10.  Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives.

Authors:  H Rubbo; R Radi; M Trujillo; R Telleri; B Kalyanaraman; S Barnes; M Kirk; B A Freeman
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

View more
  3 in total

1.  Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.

Authors:  T Sengupta; J Vinayagam; N Nagashayana; B Gowda; P Jaisankar; K P Mohanakumar
Journal:  Neurochem Res       Date:  2010-10-23       Impact factor: 3.996

Review 2.  Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction.

Authors:  Marisol Godínez-Rubí; Argelia E Rojas-Mayorquín; Daniel Ortuño-Sahagún
Journal:  Oxid Med Cell Longev       Date:  2013-04-04       Impact factor: 6.543

Review 3.  Neuroprotection by radical avoidance: search for suitable agents.

Authors:  Rüdiger Hardeland
Journal:  Molecules       Date:  2009-12-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.